Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk

Sponsor
Sheba Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT02832921
Collaborator
(none)
200
1
4
37
5.4

Study Details

Study Description

Brief Summary

The primary objective of this program is to apply a virtual reality (VR) cognitive-motor intervention (compared to active and passive control groups) to delay or slow cognitive decline of middle-aged adults who have a family history of Alzheimer's disease (AD) and thus are at particularly high risk of developing the disease.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: cognitive training by virtual reality
  • Behavioral: watching a scientific TV documentary
  • Device: treadmill
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk
Study Start Date :
Jul 1, 2016
Anticipated Primary Completion Date :
Jul 1, 2019
Anticipated Study Completion Date :
Aug 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: VR cognitive tasks + treadmill

This is the primary group of interest, in which the investigators hypothesize the greatest cognitive gains since motor activity will augment cognitive activity.

Behavioral: cognitive training by virtual reality

Device: treadmill
VR cognitive training will be augmented by walking on a treadmill, since it is well established that dual tasking-i.e. performing the VR-based cognitive effort together with a motor task, even as simple as walking on a treadmill-places greater demand on cognitive resources than a "single task".

Active Comparator: VR cognitive tasks - treadmill

This group will be an active control, receiving the VR cognitive training without treadmill walking, to examine whether the motor component augments the effect of the VR in the experimental group.

Behavioral: cognitive training by virtual reality

Sham Comparator: scientific TV documentary + treadmill

This group will watch a scientific TV documentary while walking on the treadmill. This control group will permit examination of whether the VR cognitive training, which requires an especially active cognitive effort while walking on the treadmill, is more advantageous than passively watching a scientific TV documentary while performing the same motor task as the experimental group.

Behavioral: watching a scientific TV documentary

Device: treadmill
VR cognitive training will be augmented by walking on a treadmill, since it is well established that dual tasking-i.e. performing the VR-based cognitive effort together with a motor task, even as simple as walking on a treadmill-places greater demand on cognitive resources than a "single task".

No Intervention: Passive control

This group of participants will not receive any intervention but will be assessed with the same battery of assessments as the other three groups, permitting comparisons of the cognitive and neurobiological outcomes of the intervention groups to that of the natural course of decline/deterioration of these at-risk individuals.

Outcome Measures

Primary Outcome Measures

  1. change in overall cognition- measured by averaging z-scores from 14 paper and pencil neuropsychological tests covering episodic memory and executive functions cognitive domains. [baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)]

    summary of the z-scores of all 14 paper and pencil cognitive tests

  2. change in cerebral blood flow from arterial spin labeling (ASL) [baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)]

    acquired by structural MRI using background-suppressed pseudo-continuous ASL (pcASL) featuring a 3D fast spin echo spiral sequence

Secondary Outcome Measures

  1. specific cognitive domains- average of z-scores of paper and pencil memory tests and of executive functions tests [baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)]

    summary of z-scores of executive functions tests and of episodic memory tests

  2. blood oxygenation level dependent (BOLD) functional MRI (fMRI) signal in the fronto-parietal network associated with working memory [baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)]

    T2*-weighted fMRI during an n-back working memory task; contrasts: 1-back minus 0-back; 2-back minus 0-back; 2-back minus 1-back

  3. brain resting state functional connectivity by resting state network fMRI BOLD signal correlations [baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)]

    T2*-weighted fMRI while relaxing with eyes closed; functional connectivity between seed regions of resting state networks (e.g., default mode, attentional, salience) and other regions by correlation of BOLD signal in seed regions with that in other regions

  4. hippocampal volume [baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)]

    3D T1-weighted MRI imaging

  5. frontal inferior cortex volume [baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)]

    3D T1-weighted MRI imaging

  6. white matter hyperintensity (WMH) burden [baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)]

    3D T2-FLAIR MRI imaging

  7. diffusion-tensor imaging (DTI) measures [baseline, immediately after 12-week training, and 3 months post-training (or corresponding time points in passive control group)]

    diffusion-weighted MRI imaging (DWI) to map white matter tractography

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • The participants of the study must have at least one parent with Alzheimer's disease.

  • Fluency in Hebrew, in order to understand the instructions of the cognitive tests.

  • Availability of an informant for the participant.

Exclusion Criteria:
  • Severe neurological or psychological conditions that may affect cognitive performance.

  • Substantial orthopedic limitations which prevent the use of treadmill.

  • Unstable medical condition such as an active cancer.

  • Incapability of adherence to the training program.

  • The participant is undergoing a treatment that may interfere with the study program.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sheba Medical Center Ramat Gan Israel

Sponsors and Collaborators

  • Sheba Medical Center

Investigators

  • Principal Investigator: Michal Schnaider Beeri, PhD, Sheba Medical Center/Icahn School of Medicine at Mount Sinai

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT02832921
Other Study ID Numbers:
  • SHEBA-16-2988-MSB-CTIL
First Posted:
Jul 14, 2016
Last Update Posted:
Jan 26, 2018
Last Verified:
Jan 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Sheba Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2018